Solventum Receives FDA Clearance for Combined Use of Wound Care Technologies

MT newswire2026/10/19 21:56

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

05:56 PM EDT, 10/19/2026 (MT Newswires) -- Solventum (SOLV) said late Monday it received 510(k) clearance from the US Food and Drug Administration for the combined use of Restrata synthetic electrospun fiber matrix and V.A.C. negative pressure wound therapy to support active wound healing. Restrata matrix provides structural support for soft tissue repair, while V.A.C. Therapy helps create an environment that supports tissue integration. Their combined use may allow for fewer dressing changes and a more predictable workflow for care teams, according to a statement.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Goldman Sachs Volatility Panic Index surged to 9.57, approaching its maximum value, with the largest single-day increase ranking third in history, and the combined two-day volatility setting a new record. Historical data shows that after this index has exceeded the 9.5 threshold 15 times, the S&P 500 has seen an average three-month gain of 4.6% with a success rate of 80%. However, Goldman Sachs traders warn that forced liquidations have not yet fully cleared, and the market is still searching for a bottom, but opportunities on the other side are becoming increasingly difficult to ignore.

华尔街见闻•2026/11/07 07:31